Acceleron reports second quarter 2020 operating and financial results

Acceleron pharma inc. (nasdaq:xlrn), a biopharmaceutical company dedicated to the discovery, development, and commercialization of tgf-beta superfamil

ADES Ratings Summary

ADES Quant Ranking